FDA Adverse Event Malfunction Summary report: N

BD MAX¿ ENTERIC VIRAL PANEL

MDR report key: 23828510 · Received December 17, 2025

Report

Report Number
3007420875-2025-00265
Event Type
Malfunction
Date Received
December 17, 2025
Date of Event
November 25, 2025
Report Date
February 2, 2026
Manufacturer
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
Product Code
OOI
UDI-DI
00382904439859
PMA / PMN Number
K220607
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: THE COMPLAINT INVESTIGATION FOR DISCREPANT RESULTS WITH THE BD MAX¿ ENTERIC VIRAL PANEL KIT (REF. (B)(4)) LOT 5021181 WAS PERFORMED BY THE REVIEW OF MANUFACTURING RECORDS, CUSTOMER¿S DATA ANALYSIS AND VERIFICATION OF COMPLAINTS HISTORY. THE REVIEW OF QUALITY CONTROL RECORDS OF BD MAX¿ ENTERIC VIRAL PANEL KIT LOT 5021181 REVEALED NO ANOMALIES THAT COULD EXPLAIN THE CUSTOMER¿S DISCREPANT RESULTS. CUSTOMER REPORTED FALSE POSITIVE RESULTS FOR NOROVIRUS (NOV) WITH THE BD MAX¿ ENTERIC VIRAL PANEL. ACCORDING TO CUSTOMER, THERE WAS NO REAL AMPLIFICATION OR NO SIGMOIDAL CURVES, AND SOMETIMES BUBBLES COULD BE OBSERVED IN CARTRIDGES. CUSTOMER PROVIDED RUN FILES (PDF) OF RUN RUNS 488 FROM BD MAX¿ INSTRUMENT CT3307 FOR INVESTIGATION. SAMPLES IN RUN 488 IN POSITIONS A4 AND A5 WERE IDENTIFIED AS PROBLEMATIC BY THE CUSTOMER. MANUAL PCR CURVE ADJUDICATION REVEALED STEP DISLOCATIONS IN MULTIPLE CHANNELS WERE OBSERVED, AND IT IS UNLIKELY THESE POSITIVE RESULTS ARE TRUE AMPLIFICATIONS. THESE RESULTS COULD BE RELATED TO THE BUBBLES THE CUSTOMER MENTIONED HAVING OBSERVED IN THE CARTRIDGES, SINCE MULTIPLE CHANNELS ARE IMPACTED AT THE SAME CYCLE. OVERALL, BD WAS UNABLE TO FIND THE EXACT CAUSE OF THE CUSTOMER¿S POSITIVE RESULTS, BUT BASED ON THE INVESTIGATION, NO REAGENTS ISSUE IS SUSPECTED. THERE IS NO INDICATION OF A REAGENT ISSUE BASED ON THE ANALYSIS OF THE COMPLAINTS RECEIVED FOR DISCREPANT RESULTS ON BD MAX¿ ENTERIC VIRAL PANEL ASSAY LOT 5021181. THE ROOT CAUSE WAS NOT IDENTIFIED. BD CANNOT CONFIRM THE COMPLAINT BASED ON THE INVESTIGATION THAT WAS PERFORMED. BD DID NOT INITIATE A CORRECTIVE AND PREVENTIVE ACTION (CAPA) SINCE NO NEW HAZARD WAS IDENTIFIED.

Additional Manufacturer Narrative · 0

D.2. ADDITIONAL MEDICAL DEVICE TYPE: PCH. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

REPORT 1 OF 2: IT WAS REPORTED THAT DURING USE OF BD MAX¿ ENTERIC VIRAL PANEL, A FALSE POSITIVE NOROVIRUS PATIENT RESULT WITH A WEEK PCR CURVE WAS OBTAINED. THERE WAS NO REPORT OF PATIENT IMPACT.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING USE OF BD MAX¿ ENTERIC VIRAL PANEL, A FALSE POSITIVE NOROVIRUS PATIENT RESULT WITH A WEEK PCR CURVE WAS OBTAINED. THERE WAS NO REPORT OF PATIENT IMPACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2181333 BD MAX¿ ENTERIC VIRAL PANEL GASTROINTESTINAL PATHOGEN PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM OOI GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) 5021181 00382904439859

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown